Elevated levels of glucagon, hyperglucagonaemia, are observed in several obesity-related diseases including type 2 diabetes and non-alcoholic fatty liver disease where it contributes to an increased risk of hyperglycaemia (3, 4, 5, 6, 7, 8, 9). The gene discussed is GCG; the disease is Hyperglycemia.